Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jonathan Santoro

Clinical trials sponsored by Jonathan Santoro, explained in plain language.

Not yet recruiting 1

Can an immune-targeting antibody reverse sudden losses in down syndrome?

Disease control Not yet recruiting

Down syndrome regression disorder (DSRD) causes a sudden loss of thinking, language, or daily skills in some people with Down syndrome. Researchers are testing ublituximab, an antibody that targets immune cells, in 20 adults aged 18 to 40 who have DSRD and did not respond well en…

Phase 2 • Sponsor: Jonathan Santoro • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC